ANDA 89070, held by Hospira. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 89070 (Procainamide Hydrochloride), held by Hospira, was first approved by FDA on Feb 12, 1986, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 12, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride500MG/ML · injectable;injection | Procainamide Hydrochloride | Discontinued |
| May 5, 1999 | Supplement 12Labeling | Approved | None posted |
| Dec 21, 1998 | Supplement 9Labeling | Approved | None posted |
| May 5, 1998 | Supplement 10Manufacturing | Approved | None posted |
| Feb 12, 1998 | Supplement 11Labeling | Approved | None posted |
| Aug 24, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Dec 22, 1993 | Supplement 6Manufacturing | Approved | None posted |
| Nov 22, 1991 | Supplement 5Labeling | Approved | None posted |
| Aug 16, 1990 | Supplement 4Labeling | Approved | None posted |
| Nov 23, 1988 | Supplement 2Labeling | Approved | None posted |
| Aug 12, 1988 | Supplement 3Labeling | Approved | None posted |
| Feb 12, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters